Immune checkpoint inhibitors and non-small-cell lung cancer management: 2018 update

被引：11
作者：
Abdel-Rahman, Omar [1 ]
Morris, Don [1 ]
机构：
[1] Univ Calgary, Dept Oncol, Tom Baker Canc Ctr, Calgary, AB, Canada
来源：
IMMUNOTHERAPY | 2019年 / 11卷 / 03期
关键词：
immunotherapy; NSCLC; outcome; prognosis; survival; PD-(L)1 INHIBITORS; NIVOLUMAB; DOCETAXEL; PEMBROLIZUMAB; IMMUNOTHERAPY; TOXICITIES;
D O I：
10.2217/imt-2018-0167
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：149 / 153
页数：5
相关论文
共 32 条
[1]   Smoking and EGFR status may predict outcomes of advanced NSCLC treated with PD-(L)1 inhibitors beyond first line: A meta-analysis [J].
Abdel-Rahman, Omar .
CLINICAL RESPIRATORY JOURNAL, 2018, 12 (05) :1809-1819
[2]   Immune-related musculoskeletal toxicities among cancer patients treated with immune checkpoint inhibitors: a systematic review [J].
Abdel-Rahman, Omar ;
Eltobgy, Mostafa ;
Oweira, Hani ;
Giryes, Anwar ;
Tekbas, Aysun ;
Decker, Michael .
IMMUNOTHERAPY, 2017, 9 (14) :1175-1183
[3]   Nonconventional patterns of benefit of solid tumors treated with PD-(L)1 inhibitors: a systematic review [J].
Abdel-Rahman, Omar .
IMMUNOTHERAPY, 2017, 9 (12) :995-1004
[4]   Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma: a systematic review [J].
Abdel-Rahman, Omar .
IMMUNOTHERAPY, 2016, 8 (12) :1383-1391
[5]   Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis [J].
Abdel-Rahman, Omar ;
Fouad, Mona .
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (03) :183-193
[6]  
[Anonymous], 2018, Ann Oncol
[7]  
[Anonymous], 2018, J CLIN ONCOL S
[8]   Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Yokoi, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
de Castro Carpeno, J. ;
Wadsworth, C. ;
Melillo, G. ;
Jiang, H. ;
Huang, Y. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) :1919-1929
[9]   Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection [J].
Banna, Giuseppe Luigi ;
Passiglia, Francesco ;
Colonese, Francesca ;
Canova, Stefania ;
Menis, Jessica ;
Addeo, Alfredo ;
Russo, Antonio ;
Cortinovis, Diego Luigi .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 129 :27-39
[10]  
Barlesi F, 2018, ANN ONCOL S8, V29
1234